{
    "Project Title": "A multicenter, partially-blinded, randomized, 24-week, parallel-group, non-inferiority, open-label active controlled study to compare the efficacy and safety of QVM149 with a free triple combination of salmeterol/fluticasone + tiotropium in patients with uncontrolled asthma",
    "Sponsor": "Novartis",
    "Study Number": "CQVM149B2306",
    "Protocol Version and Date": "Version v 0 2/Clean",
    "Study Title": "Efficacy study of QVM149 in uncontrolled asthma patients",
    "Phase": "3b",
    "Therapeutic Area": "Uncontrolled asthma",
    "Number of Patients": "1251",
    "Number of Sites": "Not Available",
    "Indication": "Uncontrolled asthma",
    "Duration of Treatment": "24 weeks",
    "Schedule of Assessments": "Table 6-1, section 9.3",
    "questionnaires": [
        {
            "longName": "Asthma Control Questionnaire (ACQ-7)",
            "shortName": "ACQ-7",
            "type": "PRO",
            "questionnaireSchedule": "Scheduled at clinic as per Assessment Schedule Table 6-1.",
            "questionnaireTiming": [
                "Visit number   (Period  ): 101   (Run-in  )",
                "Visit number   (Period  ): 201   (Treatment  )",
                "Visit number   (Period  ): 203",
                "Visit number   (Period  ): 204",
                "Visit number   (Period  ): TD"
            ]
        },
        {
            "longName": "Asthma Quality of Life Questionnaire (AQLQ)",
            "shortName": "AQLQ",
            "type": "PRO",
            "questionnaireSchedule": "Scheduled at clinic as per Assessment Schedule Table 6-1.",
            "questionnaireTiming": [
                "Visit number   (Period  ): 201   (Treatment  )",
                "Visit number   (Period  ): 203",
                "Visit number   (Period  ): 204",
                "Visit number   (Period  ): TD"
            ]
        }
    ]
}